[1]LeistM .GantnerF .BohlingerL .etal.Murinehepatocyteapoptosisin ducedinvitroandinvivobyTNF -alpharequirestranscriptionalarrest[J].Jlmmunol, 1994, 153∶1778~1788.
|
[2] 应越英.病理诊断[M].见:卫生部医政司编.中国常见恶性肿瘤诊治规范第二分册.原发性肝癌.第2版北京:北京医科大学、中国协和医科大学联合出版社, 1991, 14~20.
|
[3]Knodell.RG , lshakKG , BlackWC , etal.FormalationandapplicationofaNumericalscoringsystemforassessinghistologicalactivityinasymo tomaticchronicactivehepatitis[J].Hepatol, 1981, 1 (5) ∶432~435.
|
[4]OchizukiK , HayashiN .HiramatsuN , etal.FasantigenexpressioninlivertissuesofpatientswithchronichepatitisB[J].JHepatol, 1996, 24∶2~4.
|
[5] 井迥道夫.免疫学的机序の最新知见[J].日本内科杂志, 1999, 84 (2) ∶237~239.
|
[6]陈乃玲, 邓涛, 陈佩兰等.慢性肝病中凋亡蛋白Bcl-2、Bcl-XL、Bcl-2α、Bax的调节作用[J].中华内科杂志, 2000, 39 (12) ∶808~810.
|